would inappropriate for pharmaceutical manufacturers who not targets bear the high cost of the security devices
It would be inappropriate for pharmaceutical manufacturers who are not targets for falsification to bear the high cost of the security devices.
would inappropriate for pharmaceutical manufacturers who not targets bear the high cost of the security devices.